Your session is about to expire
← Back to Search
Breast Cancer and Colorectal Cancer Survivors for Anxiety
N/A
Waitlist Available
Led By Diane Von Ah, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up greater than or equal to 6 months post cancer treatment
Awards & highlights
Summary
This descriptive, cross-sectional study will evaulate and fully characterize factors associated with cognitive dysfunction in Breast Cancer (BCS) and Colorectal Cancer (CRC) survivors that have cognitive concerns, and factors associated with psychoneurological symptom cluster in BCS and CRC survivors.
Eligible Conditions
- Anxiety
- Fatigue
- Cognitive Impairment
- Sleep Disorder
- Depression
- Pain
- Survivorship
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ greater than or equal to 6 months post cancer treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~greater than or equal to 6 months post cancer treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Subjective Cognitive Dysfunction
Secondary outcome measures
Objective Cognitive Dysfunction
Trial Design
1Treatment groups
Experimental Treatment
Group I: Breast Cancer and Colorectal Cancer SurvivorsExperimental Treatment1 Intervention
The purpose of this study is to explore the factors related with cognitive concerns and other symptoms in breast and colorectal cancer survivors.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Dysfunction
2020
N/A
~690
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
1,019 Previous Clinical Trials
1,113,533 Total Patients Enrolled
26 Trials studying Anxiety
8,942 Patients Enrolled for Anxiety
Diane Von Ah, PhDPrincipal Investigator - IU
Indiana University
1 Previous Clinical Trials
68 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger